Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Free Cash Flow (2016 - 2025)

KalVista Pharmaceuticals' Free Cash Flow history spans 10 years, with the latest figure at -$40.7 million for Q2 2025.

  • On a quarterly basis, Free Cash Flow fell 174.06% to -$40.7 million in Q2 2025 year-over-year; TTM through Apr 2025 was -$120.7 million, a 35.2% decrease, with the full-year FY2025 number at -$153.4 million, down 71.83% from a year prior.
  • Free Cash Flow hit -$40.7 million in Q2 2025 for KalVista Pharmaceuticals, down from -$39.7 million in the prior quarter.
  • Over the last five years, Free Cash Flow for KALV hit a ceiling of -$14.9 million in Q2 2024 and a floor of -$40.7 million in Q2 2025.
  • Historically, Free Cash Flow has averaged -$30.0 million across 3 years, with a median of -$27.9 million in 2024.
  • Biggest five-year swings in Free Cash Flow: tumbled 50.67% in 2024 and later crashed 174.06% in 2025.
  • Tracing KALV's Free Cash Flow over 3 years: stood at -$19.8 million in 2023, then crashed by 100.27% to -$39.7 million in 2024, then dropped by 2.52% to -$40.7 million in 2025.
  • Business Quant data shows Free Cash Flow for KALV at -$40.7 million in Q2 2025, -$39.7 million in Q4 2024, and -$40.3 million in Q3 2024.